57°
Feels Like: 57°
83°
64°
85°
By David Morgan WASHINGTON (Reuters) - U.S. health advisers voted on Thursday to recommend relaxing market restrictions on GlaxoSmit...
Read More »MUMBAI (Reuters) - Drugmaker Cadila Healthcare Ltd received regulatory approval to market a new diabetes drug in India that it devel...
Read More »
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The...
Read More »
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease. The...
Read More »
By Ben Hirschler LONDON (Reuters) - Genomics and particle physics - offering different perspectives on the fundamental nature of lif...
Read More »By Deena Beasley (Reuters) - An exciting class of new cancer drugs may boost patients' odds for survival, but healthcare providers a...
Read More »(Reuters) - Johnson & Johnson is voluntarily recalling about 32 million packages of its birth control pill Cilest in Europe, Asia an...
Read More »By Laura Zuckerman (Reuters) - Human ancestors in Africa about 3.4 million years ago expanded their diets beyond the leaves and frui...
Read More »
By Lisa Maria Garza DALLAS (Reuters) - Breast cancer charity Susan G. Komen for the Cure, which suffered a publicity backlash last y...
Read More »(Reuters) - Aveo Pharmaceuticals Inc said it would cut about 62 percent of its workforce, or 140 jobs, to focus on developing its mo...
Read More »
